Insider Trading & Ownership - Skye Bioscience Inc. (SKYE)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Skye Bioscience Inc.
Goto Prev, 0, 1, 2
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-08-07
Sale
2022-01-31
1:58 pm
Skye Bioscience Inc. SKYE Emerald Health Sciences Inc.
10% Owner
2,566,666 $0.1 $256,667 124,280,934
(Direct)
View
2020-08-07
Sale(A)
2020-08-13
6:35 pm
Emerald Bioscience Inc. EMBI Emerald Health Sciences Inc.
10% Owner
2,566,666 $0.1 $256,667 123,923,501
(Direct)
View
2020-08-07
Sale
2020-08-11
3:15 pm
Emerald Bioscience Inc. EMBI Emerald Health Sciences Inc.
10% Owner
3,000,000 $0.1 $300,000 123,490,167
(Direct)
View
2020-08-07
Purchase(M)
2020-08-11
2:53 pm
Emerald Bioscience Inc. EMBI DHILLON PUNIT
CEO
1,000,000 $0.1 $100,000 10,200,000
(Direct)
View
2020-08-07
Purchase(M)
2020-08-11
2:52 pm
Emerald Bioscience Inc. EMBI HEPPELL JAMES L
Director
500,000 $0.1 $50,000 1,700,000
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-11-10
Option Award
2022-11-15
12:24 pm
N/A
2024-04-02
Skye Bioscience Inc. SKYE Rai Sukhwinder Singh
Director
973,218 $0 951,061
(Direct)
View
2018-11-01
Ownership
2022-01-31
1:58 pm
N/A
N/A
Skye Bioscience Inc. SKYE Emerald Health Sciences Inc.
10% Owner
12,893,683 $0 124,280,934
(Direct)
View
2021-12-14
Option Award
2021-12-16
7:03 pm
N/A
2031-12-14
Skye Bioscience Inc. SKYE DHILLON PUNIT
Chief Executive Officer
5,090,000 $0 6,090,000
(Direct)
View
2021-12-14
Option Award
2021-12-16
6:59 pm
N/A
2031-12-14
Skye Bioscience Inc. SKYE Arsenault Kaitlyn Melanie
Chief Financial Officer
2,770,000 $0 2,770,000
(Direct)
View
2021-12-14
Option Award
2021-12-16
6:50 pm
N/A
2031-12-14
Skye Bioscience Inc. SKYE Ward Keith Wayne
Director
250,000 $0 250,000
(Direct)
View
2021-10-04
Option Award
2021-10-05
8:42 pm
N/A
2031-10-04
Skye Bioscience Inc. SKYE Arsenault Kaitlyn Melanie
Chief Financial Officer
1,600,000 $0 2,000,000
(Direct)
View

Ownership
2021-10-05
8:40 pm
N/A
2031-09-14
Skye Bioscience Inc. SKYE Arsenault Kaitlyn Melanie
Chief Financial Officer
0 $0 400,000
(Direct)
View
2021-09-14
Option Award
2021-09-16
4:04 pm
N/A
2031-09-14
Skye Bioscience Inc. SKYE DALESANDRO MARGARET
Director
150,000 $0 400,000
(Direct)
View
2021-09-14
Option Award
2021-09-16
4:02 pm
N/A
2031-09-14
Skye Bioscience Inc. SKYE HEPPELL JAMES L
Director
150,000 $0 1,350,000
(Direct)
View
2021-09-14
Option Award
2021-09-16
4:01 pm
N/A
2031-09-14
Skye Bioscience Inc. SKYE TYLE PRAVEEN
Director
25,000 $0 275,000
(Direct)
View
2021-07-22
Option Award
2021-07-26
2:23 pm
N/A
2031-07-22
Skye Bioscience Inc. SKYE TYLE PRAVEEN
Director
250,000 $0 250,000
(Direct)
View
2020-08-07
Option Award
2020-08-12
10:29 am
N/A
2030-08-07
Emerald Bioscience Inc. EMBI DALESANDRO MARGARET
Director
250,000 $0 250,000
(Direct)
View
2020-08-07
Option Award
2020-08-11
2:53 pm
N/A
N/A
Emerald Bioscience Inc. EMBI DHILLON PUNIT
CEO
9,000,000 $0 10,200,000
(Direct)
View
2020-08-07
Option Award
2020-08-11
2:52 pm
N/A
N/A
Emerald Bioscience Inc. EMBI HEPPELL JAMES L
Director
1,000,000 $0 1,700,000
(Direct)
View
2020-08-07
Option Award
2020-08-11
2:51 pm
N/A
N/A
Emerald Bioscience Inc. EMBI KIM DENNIS D
Chief Medical Officer
4,000,000 $0 4,736,541
(Direct)
View
2020-08-07
Option Award
2020-08-11
2:50 pm
N/A
N/A
Emerald Bioscience Inc. EMBI Traistaru Elena
CFO and Secretary
1,000,000 $0 1,000,000
(Direct)
View
(A) Indicate amendment filing.
(M) Indicate average unit share price adjusted based on the original filings.
Goto Prev, 0, 1, 2